The 3 Key Objectives of Our Bone Marrow Transplant Pipeline
Our Autologous Adoptive Immunotherapy (AAIT) is a type of therapy that is only available in our Mexico center that hasn't been approved by the FDA for the treatment of cancer within the United States. AAIT utilizes a targeted natural killer cell treatment using the patient's own immune system aimed towards fighting cancer.
- Our focus is to help patients avoid and assist graft-versus-host complications seen in association with bone marrow transplants. With the assistance of the international community, Envita's biologics team is developing new methods to control immunity and speed healing in bone marrow transplant recipients.
- Our biologics team provides cost effective solutions with high-level technology for patients in need of bone marrow transplants.
- Our biologics team specializes in customized patient treatments to help them avoid bone marrow transplants in the traditional sense, while helping patients to achieve their medical goals, reduce side effects, and avoid far-to-common, life-threatening complications.